HEART FAILURE PRESERVED EJECTION FRACTION

Clinical trials for HEART FAILURE PRESERVED EJECTION FRACTION explained in plain language.

Never miss a new study

Get alerted when new HEART FAILURE PRESERVED EJECTION FRACTION trials appear

Sign up with your email to follow new studies for HEART FAILURE PRESERVED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Experimental heart drug shows promise in reducing heart stress markers

Disease control Completed

This completed Phase 2 trial tested whether the experimental drug tovinontrine could help control heart failure in patients whose hearts pump normally but still struggle. The study involved 303 adults with chronic heart failure symptoms who received either the drug or a placebo f…

Matched conditions: HEART FAILURE PRESERVED EJECTION FRACTION

Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

HEART FAILURE PRESERVED EJECTION FRACTION

Get alerted when new HEART FAILURE PRESERVED EJECTION FRACTION trials appear

Experimental heart drug shows promise in reducing heart stress markers